How renaming PCOS to PMOS could improve care for millions of women
7:29

How renaming PCOS to PMOS could improve care for millions of women

PBS NewsHour

5 chapters6 takeaways10 key terms5 questions

Overview

This video discusses the renaming of Polycystic Ovary Syndrome (PCOS) to PMOS (Polycystic and Metabolic Ovarian Syndrome) and its implications for millions of women. The change, driven by an international collaboration of experts and patients, aims to reflect a more accurate understanding of the disorder, which affects multiple body systems beyond just the ovaries. The new name emphasizes the metabolic and endocrine aspects, potentially leading to earlier and more comprehensive diagnoses, improved treatment, and better patient care by encouraging healthcare providers to consider the whole patient rather than solely reproductive concerns. It also highlights the link between PMOS and serious health risks like heart disease and type 2 diabetes, offering a path to more effective management and treatment.

How was this?

Save this permanently with flashcards, quizzes, and AI chat

Chapters

  • Polycystic Ovary Syndrome (PCOS) affects an estimated 1 in 10 women globally.
  • The condition is being renamed PMOS (Polycystic and Metabolic Ovarian Syndrome) to better reflect its nature.
  • This name change is supported by physicians, specialists, and women with the disorder.
  • The goal is to improve diagnosis, treatment, and overall care for affected individuals.
A new name can shift medical understanding and patient experience, potentially leading to more accurate diagnoses and better management of a condition that impacts millions.
The announcement of the new name PMOS in The Lancet by an international collaboration.
  • The original name, PCOS, was always a misnomer because the 'cysts' are actually immature eggs, not true cysts.
  • The condition affects multiple body systems, including endocrine and metabolic systems, not just the ovaries.
  • The new name, PMOS, aims to encompass these broader systemic effects.
  • This broader understanding encourages healthcare providers to look at the entire patient, not just the ovaries.
Correcting a long-standing misnomer helps align medical understanding with the reality of the disorder, paving the way for more holistic patient assessment.
Dr. Melanie Cree explains that the 'cysts' in PCOS are actually immature eggs, and the name has never accurately reflected the condition.
  • The hope is that the new name will prompt any doctor a patient sees (endocrinologist, gynecologist, primary care) to consider all aspects of the disorder.
  • This integrated approach aims to prevent patients from falling through the cracks or receiving incomplete care.
  • Diagnostic criteria themselves are not changing, but the approach to diagnosis and care should broaden.
  • The focus shifts from solely reproductive concerns to the entire body and condition.
By encouraging a systemic view, the name change can help ensure that patients receive comprehensive care that addresses all their symptoms and health risks, regardless of the specialist they initially consult.
An endocrinologist should consider the ovaries, a gynecologist should consider metabolic consequences, and a primary care doctor should consider all pieces of the disorder.
  • The previous focus on fertility in PCOS often ignored women not seeking pregnancy and led to misinformation.
  • PMOS is strongly linked to metabolic issues like type 2 diabetes, fatty liver, and high cholesterol.
  • Insulin resistance, a key feature of PMOS, contributes to fat storage in blood vessels.
  • This increases the risk of heart disease, the leading cause of death for women in the US, even in young individuals.
  • Early signs of arterial plaque can be detected in teenage girls with PMOS.
Highlighting the metabolic and cardiovascular risks associated with PMOS is crucial for early intervention and prevention of life-threatening conditions.
Research shows that 15-year-old girls with PMOS have thicker plaque in their neck arteries compared to their peers with regular periods.
  • Lifestyle changes for PMOS should focus on lowering insulin levels, particularly by managing intake of sugary foods.
  • Physical activity improves insulin sensitivity.
  • All individuals with PMOS, regardless of body size, experience insulin resistance and benefit from these lifestyle adjustments.
  • Stress, poor sleep, and conditions like sleep apnea can increase cortisol, which counteracts lifestyle efforts by increasing cravings and reducing energy for exercise.
  • Managing stress and sleep is as important as diet and exercise for successful lifestyle changes.
Understanding that lifestyle changes must address multiple factors, including stress and sleep, provides a more effective and compassionate approach to managing PMOS.
High cortisol levels due to stress or lack of sleep can make it harder to stick to diet and exercise plans, highlighting the need to manage these aspects too.

Key takeaways

  1. 1The renaming of PCOS to PMOS signifies a crucial shift towards recognizing the disorder's systemic metabolic and endocrine impacts, not just ovarian characteristics.
  2. 2A more accurate name encourages healthcare providers to adopt a holistic view of patients, considering all body systems affected by PMOS.
  3. 3PMOS is strongly linked to serious health risks like type 2 diabetes and heart disease, necessitating proactive screening and management.
  4. 4Insulin resistance is a core issue in PMOS, present in all affected individuals regardless of body weight, and drives many of its complications.
  5. 5Effective lifestyle management for PMOS requires addressing not only diet and exercise but also stress and sleep hygiene.
  6. 6The change in terminology aims to improve diagnostic accuracy, reduce patient frustration, and ultimately lead to better health outcomes.

Key terms

PCOS (Polycystic Ovary Syndrome)PMOS (Polycystic and Metabolic Ovarian Syndrome)Hormonal disorderMetabolic syndromeInsulin resistanceEndocrine systemOvariesImmature eggsCardiovascular diseaseCortisol

Test your understanding

  1. 1Why was the name Polycystic Ovary Syndrome (PCOS) considered a misnomer, and how does the new name PMOS address this?
  2. 2How can the renaming of PCOS to PMOS potentially improve the diagnostic process and the quality of care for affected women?
  3. 3What are the key metabolic and cardiovascular risks associated with PMOS, and why is early recognition important?
  4. 4Explain the role of insulin resistance in PMOS and how lifestyle changes can help manage it.
  5. 5Beyond diet and exercise, what other lifestyle factors are crucial for managing PMOS, according to the video?

Turn any lecture into study material

Paste a YouTube URL, PDF, or article. Get flashcards, quizzes, summaries, and AI chat — in seconds.

No credit card required